Increased vulnerability of rural children on antiretroviral therapy attending public health facilities in South Africa: A retrospective cohort study

Journal of the International AIDS Society

Volumn 13, Issue 1, 2010, Pages

  Fatti, Geoffrey ^a,b   Bock, Peter ^a,c   Grimwood, Ashraf ^a   Eley, Brian ^d  

^a Kheth'Impilo   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; CD4 LYMPHOCYTE PERCENTAGE; CHILD; COHORT ANALYSIS; FEMALE; FOLLOW UP; HAZARD RATIO; HEALTH CARE FACILITY; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; INFANT; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROBABILITY; PROPORTIONAL HAZARDS MODEL; PUBLIC HEALTH; RETROSPECTIVE STUDY; RURAL AREA; RURAL POPULATION; SCHOOL CHILD; SCORING SYSTEM; SOUTH AFRICA; TREATMENT DURATION; TREATMENT OUTCOME; URBAN AREA; ADOLESCENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; STATISTICS;

ADOLESCENT; ANTI-HIV AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HEALTH FACILITIES; HIV INFECTIONS; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES; RURAL POPULATION; SOUTH AFRICA; TREATMENT OUTCOME;

EID: 78649327506     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.1186/1758-2652-13-46     Document Type: Article

References (39)

1. UNAIDS, AIDS epidemic update 2009 UNAIDS 2009 http://www.unaids.org/en/ KnowledgeCentre/HIVData/EpiUpdate/EpiUpdArchive/2009/default.asp
2. Actuarial Society of South Africa, ASSA2003 demographic model http://assaaids.eu1.rentasite.co.za/ASSA2003-Model-3165.htm
3. Statistics South Africa, Mid-year population estimates 2009 http://www.statssa.gov.za/publications/P0302/P03022009.pdf
4. Two-year outcomes of children on non-nucleoside reverse transcriptase inhibitor and protease inhibitor regimens in a South African pediatric antiretroviral program. HB Jaspan AE Berrisford AB Boulle, Pediatric Infectious Diseases Journal 2008 27 993 998 10.1097/INF.0b013e31817acf7b
5. Antiretroviral therapy in the Northern Cape. JP Jooste AJM van Zyl A Baker W Crawford A Jassen, S Afr Med J 2008 95 12
6. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa. A Reddi SC Leeper AC Grobler R Geddes KH France GL Dorse WJ Vlok M Mntambo M Thomas K Nixon HL Holst QA Karim NC Rollins HM Coovadia J Giddy, BMC Pediatr 2007 7 13 10.1186/1471-2431-7-13 17367540
7. Antiretroviral treatment for children. B Eley MA Davies P Apolles C Cowburn H Buys M Zampoli H Finlayson S King J Nuttall, S Afr Med J 2006 96 988 993 17077930
8. Outcomes of the South African National Antiretroviral Treatment Programme for children: The IeDEA Southern Africa collaboration. M-A Davies Keiser Olivia Technau Karl Eley Brian Rabie Helena Cutsem Gilles van Giddy Janet Wood Robin Boulle Andrew Egger Matthias Moultrie Harry, S Afr Med J 2009 99 730 737 20128272
9. Challenges to Pediatric HIV Care and Treatment in South Africa. T Meyers H Moultrie K Naidoo M Cotton B Eley G Sherman, J Infect Dis 2007 196 474 481 10.1086/521116 (Pubitemid 351417241)
10. Successful paediatric HIV treatment in rural primary care in Africa. N Janssen J Ndirangu ML Newell RM Bland, Arch Dis Child 2010 95 414 421 10.1136/adc.2009.169367 19880392
11. Long-Term Outcome of Children Receiving Antiretroviral Treatment in Rural South Africa: Substantial Virologic Failure on First-Line Treatment. RE Barth HA Tempelman E Smelt AM Wensing AI Hoepelman SP Geelen, Pediatr Infect Dis J 2010 20631647
12. Global Rural-Urban Mapping Project. http://sedac.ciesin.columbia.edu/gpw/ index.jsp
13. Population Reference Bureau. http://www.prb.org/Datafinder/Geography/ Summary.aspx?region=67®ion-type=2
14. National population-based HIV prevalence surveys in sub-Saharan Africa: results and implications for HIV and AIDS estimates. JM García-Calleja E Gouws PD Ghys, Sex Transm Infect 2006 82 64 70 10.1136/sti.2006.019901 (Pubitemid 43901614)
15. Continued very high prevalence of HIV infection in rural KwaZulu-Natal, South Africa: a population-based longitudinal study. T Welz V Hosegood S Jaffar J Batzing-Feigenbaum K Herbst M-L Newell, AIDS 2007 21 1467 1472 10.1097/QAD.0b013e3280ef6af2 17589193
16. Differences in Presentation, Treatment Initiation and Response Among Children Infected With Human Immunodeficiency Virus in Urban and Rural Zambia. CG Sutcliffe JHv Dijk C Bolton-Moore M Cotham B Tambatamba WJ Moss, Pediatr Infect Dis J 2010 29 849 854 10.1097/INF.0b013e3181e753a8 20526227
17. Implementing Antiretroviral Therapy in Rural Communities: The Lusikisiki Model of Decentralized HIV/AIDS Care. M Bedelu N Ford K Hilderbrand H Reuter, J Infect Dis 2007 196 464 S468 10.1086/521114 18181695
18. Department of Health of South Africa, Guidelines for the management of HIV infected children Pretoria 2005 http://www.doh.gov.za/docs/factsheets/ guidelines/hiv/index.html
19. Socioeconomic Data and Applications Centre, Global Rural-Urban Mapping Project: International Earth Science Information Network of the Earth Institute at Columbia University http://sedac.ciesin.columbia.edu/gpw/index.jsp
20. Statistics South Africa, National Population Census 2001 http://www.statssa.gov.za/census01/html/C2001publications.asp
21. CD45-assisted PanLeucogating for accurate, cost-effective dual-platform CD4+ T-cell enumeration. D Glencross LE Scott IV Jani D Barrett G Janossy, Cytometry 2002 50 69 77 10.1002/cyto.10068 12116348
22. Antiretroviral therapy of HIV infection in infants and children in resource-limited settings: towards universal access. Recommendations for a public health approach. World Health Organization, 2006 http://www.who.int/hiv/ pub/guidelines/paediatric020907.pdf
23. Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa. KIDS-ART-LINC Collaboration, J Acquir Immune Defic Syndr 2008 49 523 531 10.1097/QAI.0b013e31818aadce 18989227
24. 2000 CDC growth charts for the United States: methods and development. RJ Kuczmarski CL Ogden SS Guo LM Grummer-Strawn KM Flegal Z Mei R Wei LR Curtin AF Roche CL Johnson, Vital Health Stat 11 2002 246 1 190 12043359
25. Determinants of child mortality in LDCs: Empirical findings from demographic and health surveys. L Wang, Health Policy 2003 65 277 299 10.1016/S0168-8510(03)00039-3 12941495
26. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. C Sutcliffe Jv Dijk C Bolton D Persaud W Moss, The Lancet Infectious Diseases 2008 8 477 489 10.1016/S1473-3099(08)70180-4 18652994
27. Markers for predicting mortality in untreated HIV-infected children in resource-limited settings: a meta-analysis. Cross Continents Collaboration for Kids Analysis and Writing Committee, AIDS 2008 22 97 105 10.1097/01.aids. 0000302262.51286.a5 18090397
28. The First 5 Years of the Family Clinic for HIV at Tygerberg Hospital: Family Demographics, Survival of Children and Early Impact of Antiretroviral Therapy. NKM van Kooten Niekerk MM Knies J Howard H Rabie M Zeier A van Rensburg N Frans HS Schaaf G Fatti F Little MF Cotton, J Trop Pediatr 2006 52 3 11 10.1093/tropej/fmi047 15947012
29. What's new? Investigating risk factors for severe childhood malnutrition in a high HIV prevalence South African setting. H Saloojee TD Maayer ML Garenne K Kahn, Scand J Public Health Suppl 2007 69 96 106 10.1080/14034950701356435 17676510
30. Mortality and loss to follow-up among HAART initiators in rural South Africa. P MacPherson M Moshabela N Martinson P Pronyk, Trans R Soc Trop Med Hyg 2009 103 588 593 10.1016/j.trstmh.2008.10.001 19012940
31. Anemia and growth failure among HIV-infected children in India: a retrospective analysis. A Shet S Mehta N Rajagopalan C Dinakar E Ramesh NM Samuel CK Indumathi W Fawzi A Kurpad, BMC Pediatrics 2009 9 37 10.1186/1471-2431-9-37 19531242
32. Antiretroviral therapy and early mortality in South Africa. A Boulle P Bock M Osler K Cohen L Channing K Hilderbrand E Mothibi V Zweigenthal N Slingers K Cloete F Abdulla, Bull World Health Organ 2008 86 678 687 10.2471/BLT.07.045294 18797643
33. Barriers to the care of HIV-infected children in rural Zambia: a cross-sectional analysis. J van Dijk C Sutcliffe B Munsanje F Hamangaba P Thuma W Moss, BMC Infectious diseases 2009 9 169 10.1186/1471-2334-9-169 19835604
34. Migration, settlement change and health in post-apartheid South Africa: Triangulating health and demographic surveillance with national census data. MA Collinson SM Tollman K Kahn, Scand J Public Health 2007 38 77 84 10.1080/14034950701356401 (Pubitemid 47241584)
35. Changes Over Time in Risk of Initial Virological Failure of Combination Antiretroviral Therapy: A Multicohort Analysis, 1996 to 2002. FC Lampe JM Gatell S Staszewski MA Johnson C Pradier MJ Gill E de Lazzari B Dauer M Youle E Fontas HB Krentz AN Phillips, Arch Intern Med 2006 166 521 528 10.1001/archinte.166.5. 521 16534038
36. Clinical Outcomes and CD4 Cell Response in Children Receiving Antiretroviral Therapy at Primary Health Care Facilities in Zambia. C Bolton-Moore M Mubiana-Mbewe RA Cantrell N Chintu EM Stringer BH Chi M Sinkala C Kankasa CM Wilson CM Wilfert A Mwango J Levy EJ Abrams M Bulterys JSA Stringer, JAMA 2007 298 1888 1899 10.1001/jama.298.16.1888 17954540
37. Provision of antiretroviral therapy to children within the public sector of South Africa. P Bock A Boulle C White M Osler B Eley, Trans R Soc Trop Med Hyg 2008 102 905 911 10.1016/j.trstmh.2008.06.010 18656217
38. Early Antiretroviral Therapy and Mortality among HIV-Infected Infants. A Violari MF Cotton DM Gibb AG Babiker J Steyn SA Madhi P Jean-Philippe JA McIntyre CST the, N Engl J Med 2008 359 2233 2244 10.1056/NEJMoa0800971 19020325
39. Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. O Keiser K Anastos M Schechter E Balestre L Myer A Boulle D Bangsberg H Touré P Braitstein E Sprinz D Nash M Hosseinipour F Dabis M May MW Brinkhof M Egger, Trop Med Int Health 2008 13 870 879 10.1111/j.1365-3156.2008.02078.x 18373510